Attralus Presents Clinical Data from Novel, Potential First-in-Class Diagnostic AT-01 for Systemic Amyloidosis at Virtual ASH 2020 ...Middle East

SOUTH SAN FRANCISCO, Calif., Dec. 6, 2020 /PRNewswire/ -- Attralus, a biopharmaceutical company focused on creating transformative medicines and diagnostics to improve the lives of patients with systemic amyloidosis, today announced clinical data from its ongoing Phase 1/2 trial assessing...

Hence then, the article about attralus presents clinical data from novel potential first in class diagnostic at 01 for systemic amyloidosis at virtual ash 2020 was published today ( Sunday 06/12/2020 - 07:00 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Attralus Presents Clinical Data from Novel, Potential First-in-Class Diagnostic AT-01 for Systemic Amyloidosis at Virtual ASH 2020 )

Also on site :

• Retired Gen. Wesley Clark tangled up in a crypto fraud suit with Burning Man buddies
• 1965 Timeless Classic Ranked Among ‘Greatest Country Songs of All Time’ Became a Long-Running No. 1 Hit
• Iran-US war latest: Trump extends pause on energy plant strikes and says talks with Tehran going ‘very well’